SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-040397
Filing Date
2015-07-01
Accepted
2015-07-01 16:15:37
Documents
6
Period of Report
2015-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v414486_8k.htm 8-K 23475
2 EXHIBIT 1.1 v414486_ex1-1.htm EX-1.1 107988
3 EXHIBIT 5.1 v414486_ex5-1.htm EX-5.1 13722
4 EXHIBIT 10.1 v414486_ex10-1.htm EX-10.1 195330
5 EXHIBIT 99.1 v414486_ex99-1.htm EX-99.1 9875
6 GRAPHIC tex99-1_logo.jpg GRAPHIC 14950
  Complete submission text file 0001144204-15-040397.txt   372391
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 15965254
SIC: 2834 Pharmaceutical Preparations